Bibek Gooptu
@bibekgooptu.bsky.social
বাবা to 2, m’husband to 1.
Resp clinician scientist.
Inflamm’n & fibrosis from atoms=>people. A1ATD, ILD.
Misfolding/conf’nal change.
FLIER AcMedSci.
UoLeic Centre for Fibrosis Res.
MIRA (Midlands ILD Res. Alliance).
Lover of things arty.
Lucky sod.
Resp clinician scientist.
Inflamm’n & fibrosis from atoms=>people. A1ATD, ILD.
Misfolding/conf’nal change.
FLIER AcMedSci.
UoLeic Centre for Fibrosis Res.
MIRA (Midlands ILD Res. Alliance).
Lover of things arty.
Lucky sod.
Creative, smart and charming:
@apropostheatre’s #TheTruthAboutTrees inspired our kids’ leaf drawings. Strong impressions from a gentle and beguiling show. Go see it! The Crate, Assembly George Sq, 11.50.
#EdFringe #EdinburghFringe #FringeForFamilies #EcoTheatre #FamilyTheatre
@apropostheatre’s #TheTruthAboutTrees inspired our kids’ leaf drawings. Strong impressions from a gentle and beguiling show. Go see it! The Crate, Assembly George Sq, 11.50.
#EdFringe #EdinburghFringe #FringeForFamilies #EcoTheatre #FamilyTheatre
August 12, 2025 at 7:16 PM
Creative, smart and charming:
@apropostheatre’s #TheTruthAboutTrees inspired our kids’ leaf drawings. Strong impressions from a gentle and beguiling show. Go see it! The Crate, Assembly George Sq, 11.50.
#EdFringe #EdinburghFringe #FringeForFamilies #EcoTheatre #FamilyTheatre
@apropostheatre’s #TheTruthAboutTrees inspired our kids’ leaf drawings. Strong impressions from a gentle and beguiling show. Go see it! The Crate, Assembly George Sq, 11.50.
#EdFringe #EdinburghFringe #FringeForFamilies #EcoTheatre #FamilyTheatre
Kids, parents, and grandma all very much enjoyed @ofalafel.bsky.social stupidest show. Wanna see a poo on a pogo stick, embellished by a bum-faced snail and a sausage bird? Course you do:
August 11, 2025 at 12:23 PM
Kids, parents, and grandma all very much enjoyed @ofalafel.bsky.social stupidest show. Wanna see a poo on a pogo stick, embellished by a bum-faced snail and a sausage bird? Course you do:
Ciao and indeed ciao #Euroserpin2025, so sorry not to get longer in Brescia drawing insights and inspiration from you all, but had a great 24 hours even so!
May 28, 2025 at 7:25 PM
Ciao and indeed ciao #Euroserpin2025, so sorry not to get longer in Brescia drawing insights and inspiration from you all, but had a great 24 hours even so!
#MIRA is up and running! Prof Louise Wain kicks us off outlining a streamlined entry system for patients who want to participate in research, actively or by allowing linkage of the information we collect clinically in any case. #LeicRespCohort
April 8, 2025 at 9:13 AM
#MIRA is up and running! Prof Louise Wain kicks us off outlining a streamlined entry system for patients who want to participate in research, actively or by allowing linkage of the information we collect clinically in any case. #LeicRespCohort
We only abandoned our #GlenfieldRespTalks briefly during the initial phases of the COVID crisis, but only now really getting back to consistent in-person meetings. So it’s just so lovely to be back in our traditional venue. People homing back to their previous seats like swallows in summer…
March 21, 2025 at 1:13 PM
We only abandoned our #GlenfieldRespTalks briefly during the initial phases of the COVID crisis, but only now really getting back to consistent in-person meetings. So it’s just so lovely to be back in our traditional venue. People homing back to their previous seats like swallows in summer…
March 6, 2025 at 7:48 AM
And we’re underway: now enrolled/randomised as first case! Congratulations to Amanda Charalambou and @nihr.bsky.social Leicester BRC team for making it happen, as well as the Leicester Rheum-Resp ecosystem.
V happy to help screen first UK case for Scleroderma Research Foundation’s platform trial, assessing treatments for SSc-ILD, today #CurePF
Plenty of Rheum in the ILD house (and vice versa), amiright
@drpujamehta1.bsky.social?
Plenty of Rheum in the ILD house (and vice versa), amiright
@drpujamehta1.bsky.social?
February 13, 2025 at 7:16 AM
And we’re underway: now enrolled/randomised as first case! Congratulations to Amanda Charalambou and @nihr.bsky.social Leicester BRC team for making it happen, as well as the Leicester Rheum-Resp ecosystem.
Oh yeah, it’s also advanced understanding of multiple conditions caused by similar molecular mechanisms - from COPD to dementias! Quite good returns from its first 3 decades…. 🎉 👏🏽 🙌🏽 🪩
#MechanismMatters #BenchANDBedside
🧵 END (for now)
#MechanismMatters #BenchANDBedside
🧵 END (for now)
February 1, 2025 at 8:09 AM
As a beneficial by-product they have helped the general development of novel strategies including iPSCs, RNA and gene-editing pushing the biotech for benefit across the board. 3/n
February 1, 2025 at 8:08 AM
This has directly facilitated the range of new treatments now in clinical trials for alpha1-antitrypsin deficiency. 2/n
February 1, 2025 at 8:08 AM
Happy 30th to the Alpha-1 Foundation! An exemplary patient-led research charity. Has enabled a lot of great science - keeping faith in bench<=>bedside ethos.
The Alpha-1 Foundation Commemorates its 30th Anniversary - Alpha-1 Foundation
The Alpha-1 Foundation (A1F) is proud to commemorate its 30th anniversary of supporting patients with Alpha-1 Antitrypsin Deficiency (Alpha-1) while [...]Read More... from The Alpha-1 Foundation Comme...
alpha1.org
February 1, 2025 at 8:07 AM
Happy 30th to the Alpha-1 Foundation! An exemplary patient-led research charity. Has enabled a lot of great science - keeping faith in bench<=>bedside ethos.
The Alpha-1 Foundation Commemorates its 30th Anniversary - Alpha-1 Foundation
The Alpha-1 Foundation (A1F) is proud to commemorate its 30th anniversary of supporting patients with Alpha-1 Antitrypsin Deficiency (Alpha-1) while [...]Read More... from The Alpha-1 Foundation Comme...
alpha1.org
February 1, 2025 at 7:46 AM
Happy 30th to the Alpha-1 Foundation! An exemplary patient-led research charity. Has enabled a lot of great science - keeping faith in bench<=>bedside ethos.
V happy to help screen first UK case for Scleroderma Research Foundation’s platform trial, assessing treatments for SSc-ILD, today #CurePF
Plenty of Rheum in the ILD house (and vice versa), amiright
@drpujamehta1.bsky.social?
Plenty of Rheum in the ILD house (and vice versa), amiright
@drpujamehta1.bsky.social?
January 14, 2025 at 6:15 PM
V happy to help screen first UK case for Scleroderma Research Foundation’s platform trial, assessing treatments for SSc-ILD, today #CurePF
Plenty of Rheum in the ILD house (and vice versa), amiright
@drpujamehta1.bsky.social?
Plenty of Rheum in the ILD house (and vice versa), amiright
@drpujamehta1.bsky.social?
Reposted by Bibek Gooptu
And the NHS actually spends less on things we consider “waste”, like admin and managers, than many other nations.
The NHS may indeed be inefficient — but it is not “bloated”. Rather, it is inefficient because it is run too lean.
More in my column 🔗 www.thetimes.com/article/1130...
The NHS may indeed be inefficient — but it is not “bloated”. Rather, it is inefficient because it is run too lean.
More in my column 🔗 www.thetimes.com/article/1130...
December 29, 2024 at 11:25 AM
And the NHS actually spends less on things we consider “waste”, like admin and managers, than many other nations.
The NHS may indeed be inefficient — but it is not “bloated”. Rather, it is inefficient because it is run too lean.
More in my column 🔗 www.thetimes.com/article/1130...
The NHS may indeed be inefficient — but it is not “bloated”. Rather, it is inefficient because it is run too lean.
More in my column 🔗 www.thetimes.com/article/1130...
Comin’ atcha #BTSWinter24! 2 presentations in first session Moore, Moore I hear you cry - well yes, that’s quite right: 4th floor, from 8.45. But I’m not on till midway through, so even laggards like me could make them.
November 28, 2024 at 6:58 AM
Comin’ atcha #BTSWinter24! 2 presentations in first session Moore, Moore I hear you cry - well yes, that’s quite right: 4th floor, from 8.45. But I’m not on till midway through, so even laggards like me could make them.
Reposted by Bibek Gooptu
Ever wondered if steroids do more harm than good in Hypersensitivity Pneumonitis? Don’t worry, the trial that is needed is on the way!
rdn.nihr.ac.uk/news/south-w...
rdn.nihr.ac.uk/news/south-w...
South West trust awarded £2m NIHR funding for global first respiratory study
The Royal Devon University Healthcare NHS Foundation Trust has received £2m from the National Institute for Health and Care Research (NIHR) for research into a health condition that adversely affects ...
rdn.nihr.ac.uk
November 22, 2024 at 12:29 PM
Ever wondered if steroids do more harm than good in Hypersensitivity Pneumonitis? Don’t worry, the trial that is needed is on the way!
rdn.nihr.ac.uk/news/south-w...
rdn.nihr.ac.uk/news/south-w...
Reposted by Bibek Gooptu
For the MedSky archives: Pretty much the most popular talk at #ACR23 last year
@drpujamehta1.bsky.social's Daltroy Lecture on Redefining #ImposterSyndrome
www.acrconvergencetoday.org/daltroy-lect...
@drpujamehta1.bsky.social's Daltroy Lecture on Redefining #ImposterSyndrome
www.acrconvergencetoday.org/daltroy-lect...
Daltroy Lecture Redefines Imposter Syndrome and Outlines Cultural Transformation - ACR Convergence Today
Puja Mehta, MD, MBBS, offered reasoning and practical steps to recognize testimonial injustice, create inclusive cultures, and develop potential actions for eliminating bias, both as individuals and a...
www.acrconvergencetoday.org
November 14, 2024 at 2:03 AM
For the MedSky archives: Pretty much the most popular talk at #ACR23 last year
@drpujamehta1.bsky.social's Daltroy Lecture on Redefining #ImposterSyndrome
www.acrconvergencetoday.org/daltroy-lect...
@drpujamehta1.bsky.social's Daltroy Lecture on Redefining #ImposterSyndrome
www.acrconvergencetoday.org/daltroy-lect...
Reposted by Bibek Gooptu
For the new BlueSky members who have left #ILDTwitter I’ve updated this starter-pack to help you find key ILD and ILD-adjacent community members here. Pls comment if I’ve missed you and I’ll add you 🫁😊
#CurePF #CureIPF #ILD
go.bsky.app/8u4KcNo
#CurePF #CureIPF #ILD
go.bsky.app/8u4KcNo
November 14, 2024 at 3:22 AM
For the new BlueSky members who have left #ILDTwitter I’ve updated this starter-pack to help you find key ILD and ILD-adjacent community members here. Pls comment if I’ve missed you and I’ll add you 🫁😊
#CurePF #CureIPF #ILD
go.bsky.app/8u4KcNo
#CurePF #CureIPF #ILD
go.bsky.app/8u4KcNo
Reposted by Bibek Gooptu
Looking at the replies on an app and not seeing porn bots or people calling me DEI
a man is standing in front of a crowd of people and looking at the camera with a surprised look on his face .
ALT: a man is standing in front of a crowd of people and looking at the camera with a surprised look on his face .
media.tenor.com
November 12, 2024 at 10:53 PM
Looking at the replies on an app and not seeing porn bots or people calling me DEI
Powerful perspective but also reminder of how insurance-based healthcare seems like a nightmare from my UK pov, despite current challenges.
#ACR24 #countdown
#PatientPerspectives
💬"Since my diagnosis with diffuse scleroderma and ILD, I have balanced the roles of patient and young pharmacist."
acrabstracts.org/abstract/my-...
#PatientPerspectives
💬"Since my diagnosis with diffuse scleroderma and ILD, I have balanced the roles of patient and young pharmacist."
acrabstracts.org/abstract/my-...
My Journey with Diffuse Scleroderma and Interstitial Lung Disease: A Pharmacist’s Perspective - ACR Meeting Abstracts
Background/Purpose: Since my diagnosis with diffuse scleroderma and ILD, I have balanced the roles of patient and young pharmacist. A duality that has surely impacted my approach to managing my condit...
acrabstracts.org
November 9, 2024 at 6:57 AM
Powerful perspective but also reminder of how insurance-based healthcare seems like a nightmare from my UK pov, despite current challenges.
Go-to music for finalising research proposals as deadlines approach?
It’s The Vaccines for me.
It’s The Vaccines for me.
October 7, 2024 at 2:50 PM
Go-to music for finalising research proposals as deadlines approach?
It’s The Vaccines for me.
It’s The Vaccines for me.
Bad-Enoch: I done a schematic
Everyone else: ??? !!!
Lung docs: Looks fine.
Everyone else: ??? !!!
Lung docs: Looks fine.
October 2, 2024 at 7:47 AM
Bad-Enoch: I done a schematic
Everyone else: ??? !!!
Lung docs: Looks fine.
Everyone else: ??? !!!
Lung docs: Looks fine.
Congratulations to my #LISCB PhD student Geander Pessoa (pic - and I believe pizza - credit to Ingrid Pessoa), seen here celebrating after winning the Kornberg Prize for best seminar at the LISCB student symposium.
September 6, 2024 at 6:54 PM
Congratulations to my #LISCB PhD student Geander Pessoa (pic - and I believe pizza - credit to Ingrid Pessoa), seen here celebrating after winning the Kornberg Prize for best seminar at the LISCB student symposium.
A proud day as a supervisor! Charlie Hitchman coming through his PhD viva w flying colours. A suitably probing discussion that sounds like it was great fun, & a worthy seal on a ‘tour de force’ (examiners’ assessment) PhD. Co-supe’d by Pietro Roversi, now in Milan, and Andrew Quigley at Harwell.
August 20, 2024 at 4:47 PM
A proud day as a supervisor! Charlie Hitchman coming through his PhD viva w flying colours. A suitably probing discussion that sounds like it was great fun, & a worthy seal on a ‘tour de force’ (examiners’ assessment) PhD. Co-supe’d by Pietro Roversi, now in Milan, and Andrew Quigley at Harwell.
Extraordinary achievements. As a med student on his firm I found him humane with patients, kind to students and outrageously storied. Wouldn’t presume this captures all that he was about, just sourcing my fond memories.
www.bbc.co.uk/news/uk-engl...
www.bbc.co.uk/news/uk-engl...
Sir Roy Calne: Pioneering Cambridge surgeon dies aged 93
Sir Roy Calne's son, Russell, says his dad was a "genius" who will be missed by those who knew him.
www.bbc.co.uk
January 8, 2024 at 6:47 AM
Extraordinary achievements. As a med student on his firm I found him humane with patients, kind to students and outrageously storied. Wouldn’t presume this captures all that he was about, just sourcing my fond memories.
www.bbc.co.uk/news/uk-engl...
www.bbc.co.uk/news/uk-engl...